SLI
1.993,99
PKT
+7,49
PKT
+0,38
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.01.22 | UBS Underweight | Barclays Capital | |
| 25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 25.01.22 | UBS Sector Perform | RBC Capital Markets | |
| 25.01.22 | UBS Neutral | UBS AG | |
| 24.01.22 | Richemont Outperform | Bernstein Research | |
| 24.01.22 | Zurich Insurance Buy | Kepler Cheuvreux | |
| 24.01.22 | ABB (Asea Brown Boveri) Buy | Kepler Cheuvreux | |
| 24.01.22 | UBS Underweight | Barclays Capital | |
| 24.01.22 | UBS Equal Weight | Barclays Capital | |
| 24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Swiss Re Outperform | Credit Suisse Group | |
| 21.01.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 21.01.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.22 | Richemont Buy | Deutsche Bank AG | |
| 21.01.22 | Richemont Overweight | Barclays Capital | |
| 20.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 20.01.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Swiss Re Overweight | Barclays Capital | |
| 20.01.22 | Richemont Neutral | Credit Suisse Group | |
| 20.01.22 | Richemont Buy | UBS AG | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.01.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 19.01.22 | UBS Buy | Kepler Cheuvreux | |
| 19.01.22 | Givaudan Underweight | Barclays Capital | |
| 19.01.22 | Richemont Buy | UBS AG | |
| 19.01.22 | Richemont Outperform | RBC Capital Markets | |
| 19.01.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 19.01.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.01.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 19.01.22 | Holcim Overweight | Barclays Capital | |
| 18.01.22 | Givaudan Neutral | UBS AG | |
| 18.01.22 | Holcim Hold | Jefferies & Company Inc. | |
| 18.01.22 | ams-OSRAM Underweight | Barclays Capital | |
| 18.01.22 | Nestlé Buy | UBS AG | |
| 18.01.22 | UBS Overweight | Barclays Capital | |
| 18.01.22 | Richemont Overweight | Morgan Stanley | |
| 18.01.22 | Givaudan Neutral | JP Morgan Chase & Co. |